Mesoblast | MSB - Interest Expense On Debt

Stock Price
2.48
Daily Change
-0.01 -0.40%
Monthly
-10.14%
Yearly
-17.88%
Q1 Forecast
2.48

Mesoblast reported $10.46M in Interest Expense on Debt for its fiscal semester ending in June of 2024.





Interest Expense On Debt Change Date
Avita Medical AUD 1.25M 100K Jun/2025
Clinuvel Pharmaceuticals AUD 2.43M 414.48K Jun/2024
Cochlear AUD 2.65M 3.05M Jun/2025
CSL USD 104M 136M Jun/2025
Paradigm Biopharmaceuticals AUD 1000 3K Jun/2025
PYC Therapeutics AUD 17K 11K Jun/2025
Ramsay Health Care AUD 316.1M 10.4M Jun/2025
Sonic Healthcare AUD 86.91M 43.94M Dec/2024
Telix Pharmaceuticals AUD 18.84M 15.45M Jun/2025